Market cap
$719.7B
Price as of
2026-10-29
Latest filing
8-K · 2026-09-17
Alerts
8
Price$116.85 +22.73% 3M daily closessample
116.8595.21
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 21INS
- Oct 12INS
- Oct 02INS
- Sep 29INS
- Sep 22INS
- Sep 17SEC
- Sep 09INS
- Sep 03INS
Company facts
SEC EDGAR registration- Name
- NovoCure Ltd
- Sector
- Health Care
- Industry
- Health Care
- Smart-money score
- +53sample, -100 to +100
- Reporting currency
- USD
Who is positioning in NVCR
sample- Insiders
- 9 insider transactions over 90 days, net selling, $204.4M
- Congress
- No member trades over 90 days
- Institutions · 13F
- 23 funds hold $10.4B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$22.4B +18.2% y/y
Q4 2024Q3 2026
Inventory$13.2B +15.3% y/y
Q4 2024Q3 2026
Accounts receivable$9.6B +10.1% y/y
Q4 2024Q3 2026
Total debt$26.8B +17.4% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $316.9B -7.8% 3M
- Sample peer B
- $328.0B -11.5% 3M
- Sample peer C
- $709.1B -12.3% 3M
- Sample peer D
- $520.1B -4.7% 3M
- Sample peer E
- $382.8B -13.2% 3M